Revision as of 13:36, 16 August 2011 edit CheMoBot (talk \| contribs) Bots 141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation ← Previous edit		Revision as of 07:23, 3 September 2011 edit undo BogBot (talk \| contribs) Bots 53,132 edits populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot Next edit →
Line 1: {{~~drugbox~~Drugbox \| UNII_Ref = {{fdacite\|correct\|FDA}}▼ \| UNII = 4Y7UR6X2PO▼ \| verifiedrevid = 443289552 \| IUPAC_name = ''O''5-methyl ''O''3-(2-oxopropyl) \| image = Aranidipine.svg▼ ~~2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate~~ ▲\| image = Aranidipine.svg <!--Clinical data--> \| CAS_number = 86780-90-7▼ \| tradename = ~~\| CAS_supplemental =~~ \| Drugs.com = {{drugs.com\|international\|aranidipine}} \| ATC_prefix = none▼ \| ~~ATC_suffix~~pregnancy_AU = <!-- A / B1 / B2 =/ B3 / C / D / X --> \| pregnancy_US = <!-- A / B / C / D / X -->▼ \| ATC_supplemental = ▼ \| pregnancy_category = ▼ \| PubChem = 2225▼ \| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->▼ \| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->▼ \| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->▼ \| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->▼ \| legal_status = Rx-only▼ \| routes_of_administration = Oral▼ <!--Pharmacokinetic data--> \| bioavailability = = ▼ \| protein_bound = = ▼ \| metabolism = = ▼ \| elimination_half-life = ▼ \| excretion = = ▼ <!--Identifiers--> ▲\| CAS_number = 86780-90-7 ▲\| ATC_prefix = none \| ATC_suffix = ▲\| ATC_supplemental = ▲\| PubChem = 2225 \| DrugBank_Ref = {{drugbankcite\|correct\|drugbank}} \| DrugBank = = ▲\| UNII_Ref = {{fdacite\|correct\|FDA}} ▲\| UNII = 4Y7UR6X2PO \| KEGG_Ref = {{keggcite\|correct\|kegg}} \| KEGG = D01562 \| C=19 \| H=20 \| N=2 \| O=7▼ <!--Chemical data--> \| molecular_weight = 388.37 g/mol▼ ▲\| C=19 \| H=20 \| N=2 \| O=7 \| smiles = CC1=C(C(C(=C(N1)C)C(=O)OCC(=O)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC▼ ▲\| molecular_weight = 388.37 g/mol ▲\| bioavailability = ▲\| smiles = CC1=C(C(C(=C(N1)C)C(=O)OCC(=O)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC ▲\| protein_bound = ▲\| metabolism = ▲\| elimination_half-life = ▲\| excretion = ~~\| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->~~ ▲\| pregnancy_US = <!-- A / B / C / D / X --> ▲\| pregnancy_category= ▲\| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> ▲\| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> ▲\| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> ▲\| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> ▲\| legal_status = Rx-only ▲\| routes_of_administration = Oral }} '''Aranidipine''' ([[International Nonproprietary Name\|INN]], trade name '''Sapresta''') is a [[calcium channel blocker]].

Aranidipine: Difference between revisions